Company profile: Reverba
1.1 - Company Overview
Company description
- Provider of patient engagement solutions for pharmaceutical and biotechnology companies, including clinical patient engagement programs powered by the reverbaBRIDGE platform, global clinical trial optimization with patient-centered approaches and real-time data insights, expert recruitment, tech-enabled relationship management and automation, and total compliance with HIPAA, GDPR, and FDA.
Products and services
- Advanced Technology: Reverba architects the platform-based reverbaBRIDGE to streamline patient engagement and manage relationships throughout clinical development and commercialization
- Global Clinical Trial Optimization: Reverba supplies data-driven services that improve trial design, recruitment, and participation experience using patient-centered approaches and real-time data insights to refine decisions and accelerate enrollment
- Clinical Patient Engagement Programs: Reverba delivers end-to-end programs enhancing patient involvement in clinical trials from awareness through enrollment and retention, leveraging reverbaBRIDGE to support engagement across these stages
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Reverba
Bioassay Online
HQ: Germany
Website
- Description: Provider of creation and implementation of bioanalytical assays in pharmacology, immunology, and toxicology, offering potency assay development; GMP validation, lot release testing, and stability studies; development and execution of potency assays for biologics, proteins, monoclonal antibodies, vaccines, gene therapies, and APIs; and efficacy models and safety assessments for biosimilars or APIs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bioassay Online company profile →
Inclinix
HQ: United States
Website
- Description: Provider of customized Phase I-IV clinical trial enrollment solutions for pharmaceutical, biotechnology, and medical device organizations. A division of Inclinix-PMG Holdings, Inc., Inclinix combines the sites of PMG Research Inc. with premier patient recruitment solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Inclinix company profile →
Xcenda
HQ: United States
Website
- Description: Provider of strategic consultancy and managed markets agency services delivering strategic insights, health economics and outcomes research (HEOR) expertise, and reimbursement support to global companies and emerging pre-commercialization phase firms, with 20+ years of real-world experience.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Xcenda company profile →
AnalytiCon Discovery
HQ: Germany
Website
- Description: Provider of natural product-based R&D for pharmaceutical, agrochemical, food & beverage, and cosmetic industries, offering drug discovery from plant and microbial biosynthetic products; 25,000-microorganism strain and 20,000 plant partition collections; liquid, solid, and membrane fermentation; high-throughput isolation of pure natural products; and medicinal chemistry optimization and SAR.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AnalytiCon Discovery company profile →
Syntactx
HQ: United States
Website
- Description: Provider of global clinical research services specializing in complex clinical trials, offering consulting across all phases, biostatistics and statistical programming, clinical evidence and post-market studies, clinical trial safety with in-house medical monitors and MeDRA coders, data management and EDC, and field clinical engineering staffing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Syntactx company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Reverba
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Reverba
2.2 - Growth funds investing in similar companies to Reverba
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Reverba
4.2 - Public trading comparable groups for Reverba
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →